Our technology

The retina is formed from the same cells as the brain and is therefore an integral part of the central nervous system. Effects of abnormalities in the structure and/or functioning of the brain can be detected in the retina.

diaMentis is developing a diagnostic tool from specific biosignatures in the retina. It is therefore possible to perform a more accurate and faster diagnosis and to more easily evaluate the choice of a treatment.

A “Software as a Medical Device” to support earlier diagnosis

The term “Software as a Medical Device” (SaMD) is defined by the FDA as a software intended to be used for medical purposes without being part of a hardware medical device.

The term “Software as a Medical Device” (SaMD) is defined by the FDA as a software intended to be used for medical purposes without being part of a hardware medical device.

diaMentis technology platform is based on an SaMD used in combination with various ERG devices commercially available and already approved.

Acquisition of required information

Clinical data and patient ERG

Analysis process and interpretation

Algorithms, computation engine, prediction models, artificial intelligence

Database, prediction criteria

Results sent to referring physicians

Analysis report, prediction and differentiation between pathologies